{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:24Z","timestamp":1790488944814,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1191,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:p>Urokinase\u2010type plasminogen activator receptor (UPA\u2010R\u2010CD87) is a GPI\u2010anchored membrane protein which promotes the generation of plasmin on the surface of many cell types, probably facilitating cellular extravasation and tissue invasion. A flow cytometric quantitative analysis of expression levels for UPA\u2010R was performed on fresh blast cells from patients with acute myeloid leukaemia (AML, <jats:italic>n<\/jats:italic>\u2003=\u200374), acute lymphoblastic leukaemia (ALL, <jats:italic>n<\/jats:italic>\u2003=\u200324), and biphenotypic leukaemia (BAL, <jats:italic>n<\/jats:italic>\u2003=\u20033) using two CD87 monoclonal antibodies (McAbs) (3B10 and VIM5). Peripheral blood and bone marrow (BM) cells from 15 healthy adults served as controls. Using 3B10 McAb, UPA\u2010R was expressed (&gt;99%) by blood monocytes, neutrophils, and BM myelomonocytic precursors in controls, whereas resting T and B lymphocytes, and CD34<jats:sup>+<\/jats:sup> cells were UPA\u2010R negative. We also attempted to clarify whether UPA\u2010R has a role in mediating neutrophil functions. Oriented locomotion induced by different chemotaxins and lysozyme release by granules stimulated with fMLP or PMA were significantly decreased when UPA\u2010R was neutralized by CD87 McAb. In contrast, the anti\u2010UPA\u2010R McAb had no effect on superoxide anion generation of normal neutrophils. Blasts from AML showed a heterogenous pattern of expression for the UPA\u2010R McAbs, with reactivity strictly dependent on FAB subtype. The highest UPA\u2010R expression was seen in the M5 group: all patients tested (<jats:italic>n<\/jats:italic>\u2003=\u200320) showed strong positivity for the UPA\u2010R McAb whereas only 12% (3\/24) of ALL patients were CD87 positive, and 2\/3 of BAL patients showed a dim expression for CD87. The number of receptors expressed by blast cells in 6\/74 (8.1%) AML patients was higher than those of normal samples; in addition, since co\u2010expression of UPA\u2010R and CD34 was not found in normal haemopoietic cells, it may be postulated that CD87 can be used alone (when overexpressed) or in combination with CD34 for the detection of minimal residual disease. Results also indicated that patients with UPA\u2010receptors &gt;12\u2003\u00d7\u200310<jats:sup>3<\/jats:sup> ABC\/cell, irrespective of FAB subtype, had a greater tendency for cutaneous and tissue infiltration and a higher frequency of chromosome abnormalities, thus suggesting the concept that cellular UPA\u2010R content positively correlates with the invasive potential of AML cells. The combination of higher UPA\u2010R positivity, abnormalities of chromosome 11, and M5 FAB morphology may identify a peculiar subset of AML, characterized by a more aggressive clinical course.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00932.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:05:30Z","timestamp":1047362730000},"page":"110-123","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Expression and functional role of urokinase\u2010type plasminogen activator receptor in normal and acute leukaemic cells"],"prefix":"10.1111","volume":"103","author":[{"family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Castoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Castagnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Spisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Latorraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Focarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Traniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Ben\u00e8 M.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4303242.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.10.3503"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.12.3427.3427"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.154.4.1817","article-title":"Human urokinase\u2010type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type 3 and calcium","volume":"154","author":"Cao D.","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"Castoldi G.L.&Cuneo A.(1996) Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes.Acute Myelogenous Leukaemia and Myelodysplasia(ed. by B. Lowemberg) pp.1932. Bailli\u00e8re Tindall London.","DOI":"10.1016\/S0950-3536(96)80035-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05243.x"},{"key":"e_1_2_6_9_2","unstructured":"Garni\u2010Wagner B.A.&Todd R.F.(1995) Two epitopes within the ligand binding domain in the human urokinase receptor are defined by select\u2003mAb.Leukocyte Typing V: White Cell Differentiation Antigens(ed. by S. F. Schlossmanet al) Vol. 1 pp.945949. Oxford University Press."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118611"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.58.5.533"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117114"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4049\/jimmunol.156.1.297","article-title":"Urokinase\u2010type plasminogen activator receptor recversibly dissociates from complement receptor type III (alpha M beta 2\u2032 CD11b\/CD18) during neutrophil polarization","volume":"156","author":"Kindzelskii A.L.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990180402"},{"key":"e_1_2_6_15_2","first-page":"1570","article-title":"Abnormal expression of N\u2010CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia","volume":"7","author":"Lanza F.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_16_2","first-page":"7","article-title":"Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results?","volume":"40","author":"Lanza F.","year":"1996","journal-title":"European Journal of Histochemistry"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400794"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19970615)30:3<134::AID-CYTO4>3.0.CO;2-L"},{"key":"e_1_2_6_19_2","first-page":"374","article-title":"Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, 3\u20137 November, 1993","volume":"79","author":"Lanza F.","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03374.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02644767"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.4049\/jimmunol.144.5.1841","article-title":"Structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human polymorphonuclear phagocytes","volume":"144","author":"Mizukami I.","year":"1990","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_23_2","unstructured":"Papa S.&Lanza F.(1996)Immunophenotyping Hematological Malignancies. Luigi & Ponzio Editore Pavia."},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V83.3.808.808","article-title":"The receptor for urokinase type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils","volume":"83","author":"Plesner T.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_25_2","first-page":"15","article-title":"Quantitation of hemopoietic cell antigens in flow cytometry","volume":"40","author":"Poncelet P.","year":"1996","journal-title":"European Journal of Histochemistry"},{"key":"e_1_2_6_26_2","first-page":"1059","article-title":"Urokinase\u2010type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas","volume":"138","author":"Pyke C.","year":"1991","journal-title":"American Journal of Pathology"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood.V88.8.3185.bloodjournal8883185","article-title":"Mac\u20101 (CD11b\/ CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells","volume":"88","author":"Simon D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_28_2","first-page":"1268","article-title":"Cytokine\u2010specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes","volume":"84","author":"Sitrin R.G.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0898-6568(96)00049-6"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027314419843"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-9499(92)90091-U"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90003-2"},{"key":"e_1_2_6_33_2","unstructured":"Todd R.F. Barnathan E.S. Bohuslav J. Chapman A. Cohen R.L. Felez J. Howell J. Johnson J.G. Knapp W. Kramer M. Miles L.A. Nykjaer A. Ralkiaer E. Schuren E.(1995) CD87 cluster workshop report.Leukocyte Typing V: White Cell Differentiation Antigens(ed. by S. F. Schlossmanet al) Vol. 1 pp.932939. Oxford University Press."},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5281.1551"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.152.9.4630","article-title":"Physical association of complement receptor type 3 and urokinase type plasminogen activator receptor in neutrophil membranes","volume":"152","author":"Xue W.","year":"1994","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60073-3"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.137.2.387"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00932.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00932.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00932.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:03:17Z","timestamp":1698454997000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00932.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00932.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00932.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}